Czech Republic - English
Public Scientific Service (VPOIS)
This webpage is established to meet the obligation to provide Publicly Accessible Scientific Service (VPOIS) following Act No. 378/2007 Coll., As amended (Section 33 (3) (g) (1)).
For all medicinal products available from Novavax you will find:
- Summary of Product Characteristics (SPC)
- Package Leaflet (PL)
In accordance with Act No. 378/2007 Coll., on Pharmaceuticals and on Amendments to Some Related Acts (Act on Pharmaceuticals). More detailed information on individual products and their availability can be found on the website of the State Institute for Drug Control (SUKL).
Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted)
On the market in the Czech Republic: Yes
Do you have a medical or scientific question about a Novavax medicinal product? Get in touch with Novavax Medical Information experts who will provide tailored, evidence-based, balanced, and up-to-date medical information.
You may request medical information via ONE of the following ways:
- Option 1: Complete and submit a Medical Information Request Form
- Option 2: Call +420 228 880 267 between 09:00-17:00, Monday – Friday